NFE2L2 and Huntington disease: According to several in vitro studies, NRF2 activation can play a protective role in the reduction of mHtt-induced toxicity, while in HD patients the initiation of the NRF2–ARE system in striatal cells in response to OS failed because of the concurrent activation of the autophagy pathway [114,115].